CStone Pharmaceuticals (CSPHF)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.145 (16.96%)
At close: Sep 23, 2025

CStone Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
1,2903783717081,2351,496
Upgrade
Market Cap Growth
415.05%1.99%-47.65%-42.68%-17.43%11.69%
Upgrade
Enterprise Value
1,2483062595398531,182
Upgrade
Last Close Price
1.000.230.320.591.241.13
Upgrade
PS Ratio
45.636.785.6710.1432.199.40
Upgrade
PB Ratio
29.337.585.7510.876.503.31
Upgrade
P/TBV Ratio
57.9213.629.2616.866.903.31
Upgrade
EV/Sales Ratio
43.765.483.957.7322.227.43
Upgrade
Debt / Equity Ratio
1.240.980.800.640.140.03
Upgrade
Asset Turnover
0.150.270.280.250.080.31
Upgrade
Inventory Turnover
1.380.852.444.86--
Upgrade
Quick Ratio
1.201.181.441.292.034.91
Upgrade
Current Ratio
1.441.601.561.322.104.91
Upgrade
Return on Equity (ROE)
-96.36%-22.23%-81.05%-109.00%-92.28%-44.92%
Upgrade
Return on Assets (ROA)
-16.93%-3.90%-21.93%-29.16%-37.90%-20.33%
Upgrade
Return on Capital (ROIC)
-30.56%-7.74%-46.53%-53.86%-51.74%-24.71%
Upgrade
Earnings Yield
-4.08%-3.31%-13.98%-18.49%-24.47%-12.50%
Upgrade
FCF Yield
--12.44%-22.41%-12.51%-20.08%-5.89%
Upgrade
Buyback Yield / Dilution
-1.61%-1.04%-7.69%-0.66%-11.39%-20.69%
Upgrade
Updated Sep 20, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.